# TENDU Vaccine in Patients With Relapse After Primary Radical Prostatectomy

> **NCT04701021** · PHASE1 · COMPLETED · sponsor: **Ultimovacs ASA** · enrollment: 12 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **BIOLOGICAL:** TENDU

## Key facts

- **NCT ID:** NCT04701021
- **Lead sponsor:** Ultimovacs ASA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-17
- **Primary completion:** 2023-08-16
- **Final completion:** 2023-08-16
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2024-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04701021

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04701021, "TENDU Vaccine in Patients With Relapse After Primary Radical Prostatectomy". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04701021. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*